Table 2.

Characteristics of expert consensus related to Duchenne muscular dystrophy.

Study	Country	Objective	Method to achieve consensus	Panel participants	Databases used	Patient inclusion in consensus	Evidence grading system
Aartsma-Rus (19)	The Netherlands	Diagnosis	Delphi	Medical geneticists, neurologist, neuropediatricians, patient advocates, genetic counselors	MEDLINE, Embase	No	GRADE
Araujo et al. (21)	Brazil	Diagnosis and treatment	Delphi	Neurologists, geneticists, pediatricians, cardiologists	Cochrane Library, Web of Science, Science Citation Index	No	NR
Bamaga et al. (22)	Saudi Arabia	Treatment during the COVID-19 pandemic	NR	Neurologists and pediatricians	NR	No	NR
Bernert et al. (23)	Germany	Treatment	NR	Neurologists and neuropediatricians	NR	No	NR
Fratter et al. (24)	UK	Diagnosis and treatment	NR	Medical geneticists	NR	No	NR
Jumah et al. (25)	Saudi Arabia	Diagnosis, treatment, and patient education	NR	Neurologists, cardiologists, geneticists	NR	No	NR
Osorio et al. (20)	Spain	Diagnosis, treatment and follow-up	NR	Neurologists, neuropediatricians, rehabilitators	MEDLINE/PubMed, Cochrane Library, Google Scholar	No	AAN criteria
Quinlivan et al. (26)	UK	Treatment	Unanimous agreement	Neurologists, cardiologists, endocrinologists, clinical psychologists	NR	Yes	NR

GRADE, Grading of Recommendations Assessment, Development and Evaluation; NR, Not reported; AAN, American Academy of Neurology.